Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
Go back to Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026| Tempest Trading Technologies, Inc. (NASDAQ: TPST) | Delayed: 0.77 -0.2 (20.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.97 | 52 Week High | $0.01 | |||
| Open | $0.92 | 52 Week Low | $0.00 | |||
| Day High | $0.94 | P/E | N/A | |||
| Day Low | $0.77 | EPS | $0.00 | |||
| Volume | 1,898,823 | |||||
